239 related articles for article (PubMed ID: 24958550)
1. [Sprue-like enteropathy due to olmesartan: a case report].
Agudo Fernández S
Gastroenterol Hepatol; 2015 Feb; 38(2):108-9. PubMed ID: 24958550
[No Abstract] [Full Text] [Related]
2. Sprue-like enteropathy linked to olmesartan.
Campos Ruiz A; Urtasun Arlegui L; Marra-López Valenciano C
Rev Esp Enferm Dig; 2016 May; 108(5):292-3. PubMed ID: 26925975
[TBL] [Abstract][Full Text] [Related]
3. [A new spruelike disease as a cause of severe diarrhea].
Halevy D; Teeuwen U; Kohlhof P
Dtsch Med Wochenschr; 2014 Nov; 139(45):2290-3. PubMed ID: 25350242
[TBL] [Abstract][Full Text] [Related]
4. Sprue-like enteropathy, do not forget olmesartan!
Melis C; Struyve M; Steelandt T; Neuville B; Deraedt K
Dig Liver Dis; 2018 Jun; 50(6):621-624. PubMed ID: 29625908
[No Abstract] [Full Text] [Related]
5. Olmesartan-Induced Enteropathy.
Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
[TBL] [Abstract][Full Text] [Related]
6. Severe spruelike enteropathy due to olmesartan.
Fiorucci G; Puxeddu E; Colella R; Paolo Reboldi G; Villanacci V; Bassotti G
Rev Esp Enferm Dig; 2014 Feb; 106(2):142-4. PubMed ID: 24852741
[TBL] [Abstract][Full Text] [Related]
7. [In diarrhea of unknown origin also think of olmesartan!].
Storr M
MMW Fortschr Med; 2015 Mar; 157(4):34. PubMed ID: 25743974
[No Abstract] [Full Text] [Related]
8. [Enteropathy by olmesartan].
Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
[No Abstract] [Full Text] [Related]
9. Olmesartan-related sprue-like enteropathy.
Bhat N; Anupama NK; Yelsangikar A; Vizhi K
Indian J Gastroenterol; 2014 Nov; 33(6):564-7. PubMed ID: 25303875
[TBL] [Abstract][Full Text] [Related]
10. [Enteropathy associated with chronic use of olmesartan].
Téllez A; Pellicé M; Llobell A; Milisenda JC
Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
[No Abstract] [Full Text] [Related]
11. Sprue-like enteropathy due to olmesartan.
Muñoz-Muñoz C; López-Vivancos J; Huaman W; García-Cors M
Rev Esp Enferm Dig; 2015 Oct; 107(10):647-8. PubMed ID: 26437988
[TBL] [Abstract][Full Text] [Related]
12. [Severe enteropathy with villous atrophy olmesartan medoxomil-associated].
Nunge D; Eoche M; Fumery M; Nguyen-Khac E; Gras V; Andréjak M
Therapie; 2013; 68(6):419-21. PubMed ID: 24246126
[No Abstract] [Full Text] [Related]
13. Olmesartan: sprue-like enteropathy.
Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan-associated sprue-like enteropathy.
Stanich PP; Yearsley M; Meyer MM
J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
[No Abstract] [Full Text] [Related]
15. Systematic review: Sprue-like enteropathy associated with olmesartan.
Ianiro G; Bibbò S; Montalto M; Ricci R; Gasbarrini A; Cammarota G
Aliment Pharmacol Ther; 2014 Jul; 40(1):16-23. PubMed ID: 24805127
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan-induced enteropathy treated with budesonide.
Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
[TBL] [Abstract][Full Text] [Related]
17. Olmesartan: sprue-like enteropathy.
Prescrire Int; 2016 May; 25(171):130-1. PubMed ID: 27280200
[TBL] [Abstract][Full Text] [Related]
18. Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use.
Sáez González E; Díaz Jaime FC; Del Val Antoñana A
Rev Esp Enferm Dig; 2016 Oct; 108(10):685-686. PubMed ID: 27109007
[TBL] [Abstract][Full Text] [Related]
19. New Onset Villous Atrophy in a Patient With Celiac Disease.
Cartee AK; Reyes Genere JP; Oxentenko AS
Gastroenterology; 2018 Oct; 155(4):988-989. PubMed ID: 30025705
[No Abstract] [Full Text] [Related]
20. Olmesartan enteropathy: an important cause of malabsorption and diarrhoea.
Cook DR
Intern Med J; 2020 Jan; 50(1):130-132. PubMed ID: 31943610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
